IGF-I stimulates CCN5/WISP2 gene expression in pancreatic β-cells, which promotes cell proliferation and survival against streptozotocin

Endocrinology

Volumn 155, Issue 5, 2014, Pages 1629-1642

  Chowdhury, Subrata ^a   Wang, Xiao ^c   Srikant, Coimbatore B ^a   Li, Qing ^a   Fu, Min ^b   Gong, Ying Jia ^a   Ning, Guang ^c   Liu, Jun Li ^a,d  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^d Montreal Diabetes Research Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; COMPLEMENTARY DNA; CYCLIN D1; GLUCOSE TRANSPORTER 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE B; STREPTOZOCIN;

ANIMAL CELL; ARTICLE; CELL DIVISION; CELL FRACTIONATION; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CONFOCAL MICROSCOPY; CYTOSOLIC FRACTION; DNA FRAGMENTATION; DNA SYNTHESIS; DOWN REGULATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; IMMUNOFLUORESCENCE; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WILD TYPE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CELL LINE; CELL PROLIFERATION; CYCLIN D1; DRUG RESISTANCE; GENE SILENCING; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-SECRETING CELLS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISLETS OF LANGERHANS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECOMBINANT PROTEINS; STREPTOZOCIN; TISSUE CULTURE TECHNIQUES; UP-REGULATION;

EID: 84899451176     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1735     Document Type: Article

References (46)

1. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A. The somatomedin hypothesis: 2001. Endocr Rev. 2001;22:53-74. (Pubitemid 32187803)
2. Liu JL. Does IGF-I stimulate pancreatic islet cell growth? Cell Biochem Biophys. 2007;48:115-125.
3. Bergerot I, Fabien N, Maguer V, Thivolet C. Insulin-like growth factor-1 (IGF-1) protectsNODmice from insulitis and diabetes. Clin Exp Immunol. 1995;102:335-340.
4. Ohneda K, UlshenMH,Fuller CR, D'Ercole AJ, Lund PK. Enhanced growth of small bowel in transgenic mice expressing human insulinlike growth factor I. Gastroenterology. 1997;112:444-454. (Pubitemid 27078831)
5. Robertson K, Lu Y, De Jesus K, et al.Ageneral and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes. Am J Physiol Endocrinol Metab. 2008;294:E928-E938.
6. Dhar K, Banerjee S, Dhar G, Sengupta K, Banerjee SK. Insulin-like growth factor-1 (IGF-1) induces WISP-2/CCN5 via multiple molecular cross-talks and is essential for mitogenic switch by IGF-1 axis in estrogen receptor-positive breast tumor cells. Cancer Res. 2007; 67:1520-1526. (Pubitemid 46383375)
7. Delmolino LM, Stearns NA, Castellot JJ. COP-1, a member of the CCN family, is a heparin-induced growth arrest specific gene in vascular smooth muscle cells. J Cell Physiol. 2001;188:45-55. (Pubitemid 32476495)
8. Fritah A, Saucier C, De Wever O, et al. Role of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells. Mol Cell Biol. 2008;28:1114-1123. (Pubitemid 351160067)
9. Holbourn KP, Malfois M, Acharya KR. First structural glimpse of CCN3andCCN5multifunctional signaling regulators elucidated by small angle X-ray scattering. J Biol Chem. 2011;286:22243-22249.
10. Brigstock DR, Goldschmeding R, Katsube KI, et al. Proposal for a unified CCN nomenclature. Mol Pathol. 2003;56:127-128. (Pubitemid 36461474)
11. Holbourn KP, Acharya KR, Perbal B. The CCN family of proteins: structure-function relationships. Trends Biochem Sci. 2008;33: 461-473.
12. Charrier A, Brigstock DR. Regulation of pancreatic function by connective tissue growth factor (CTGF, CCN2). Cytokine Growth Factor Rev. 2013;24:59-68.
13. HenleyKD,Gooding KA, EconomidesAN,GannonM.Inactivation of the dual Bmp/Wnt inhibitor Sostdc1 enhances pancreatic islet function. Am J Physiol Endocrinol Metab. 2012;303:E752-E761.
14. GuneyMA,Petersen CP, Boustani A, et al. Connective tissue growth factor acts within both endothelial cells and βcells to promote proliferation of developing βcells. Proc Natl Acad Sci USA. 2011;108: 15242-15247.
15. Crawford LA, Guney MA, Oh YA, et al. Connective tissue growth factor (CTGF) inactivation leads to defects in islet cell lineage allocation and βcells proliferation during embryogenesis. Mol Endocrinol. 2009;23:324-336.
16. Xiong X, Wang X, Li B, et al. Pancreatic islet-specific overexpression of Reg3 β protein induced the expression of pro-islet genes and protected mice against streptozotocin-induced diabetes mellitus. Am J Physiol Endocrinol Metab. 2011;300:E669-E680.
17. Getty-Kaushik L, Richard AM, Deeney JT, Krawczyk S, Shirihai O, Corkey BE. The CB1 antagonist rimonabant decreases insulin hypersecretion in rat pancreatic islets. Obesity (Silver Spring). 2009; 17:1856-1860.
18. Lu Y, Herrera PL, Guo Y, et al. Pancreatic-specific inactivation of IGF-I gene causes enlarged pancreatic islets and significant resistance to diabetes. Diabetes. 2004;53:3131-3141. (Pubitemid 39564488)
19. Lu Y, Ponton A, Okamoto H, Takasawa S, Herrera PL, Liu JL. Activation of the Reg family genes by pancreatic-specific IGF-I gene deficiency and after streptozotocin-induced diabetes in mouse pancreas. Am J Physiol Endocrinol Metab. 2006;291:E50-E58. (Pubitemid 44035309)
20. Liu L, Liu JL, Srikant CB. Reg2 protects mouse insulinoma cells from streptozotocin-induced mitochondrial disruption and apoptosis. Growth Factors. 2010;28:370-378.
21. Terui Y, Furukawa Y, Kikuchi J, Saito M. Apoptosis during HL-60 cell differentiation is closely related to aG0/G1 cell cycle arrest. J Cell Physiol. 1995;164:74-84. doi: 10.1210/en.2013-1735
22. Russo JW, Castellot JJ. CCN5: biology and pathophysiology. J Cell Commun Signal. 2010;4:119-130.
23. Dhar G, Mehta S, Banerjee S, et al. Loss of WISP-2/CCN5 signaling in human pancreatic cancer: a potential mechanism for epithelialmesenchymal- transition. Cancer Lett. 2007;254:63-70. (Pubitemid 47058806)
24. Cozar-Castellano I, Takane KK, Bottino R, Balamurugan AN, Stewart AF. Induction of βcells proliferation and retinoblastoma protein phosphorylation in rat and human islets using adenovirusmediated transfer of cyclin-dependent kinase-4 and cyclin D1. Diabetes. 2004;53:149-159. (Pubitemid 38044709)
25. Fatrai S, Elghazi L, Balcazar N, et al. Akt inducesβcells proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity. Diabetes. 2006;55:318-325. (Pubitemid 43343259)
26. Hammarstedt A, Hedjazifar S, Jenndahl L, et al. WISP2 regulates preadipocyte commitment and PPARγ activation by BMP4. Proc Natl Acad Sci USA. 2013;110:2563-2568.
27. Sabbah M, Prunier C, Ferrand N, et al. CCN5, a novel transcriptional repressor of the transforming growth factor β signaling pathway. Mol Cell Biol. 2011;31:1459-1469.
28. Wiesman KC, Wei L, Baughman C, Russo J, Gray MR, Castellot JJ. CCN5, a secreted protein, localizes to the nucleus. J Cell Commun Signal. 2010;4:91-98.
29. Zhang R, Averboukh L, Zhu W, et al. Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation. Mol Cell Biol. 1998;18:6131-6141. (Pubitemid 28450564)
30. Ohkawa Y, Ohmi Y, Tajima O, Yamauchi Y, Furukawa K, Furukawa K. Wisp2/CCN5 up-regulated in the central nervous system of GM3-only mice facilitates neurite formation in Neuro2a cells via integrin-Akt signaling. Biochem Biophys Res Commun. 2011;411: 483-489.
31. Timpl R, Sasaki T, Kostka G, Chu ML. Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol. 2003;4: 479-489. (Pubitemid 36648593)
32. Kok K, Geering B, Vanhaesebroeck B. Regulation of phosphoinositide 3-kinase expression in health and disease. Trends Biochem Sci. 2009;34:115-127.
33. Ono F, Nakagawa T, Saito S, et al.Anovel class II phosphoinositide 3-kinase predominantly expressed in the liver and its enhanced expression during liver regeneration. J Biol Chem. 1998;273:7731- 7736. (Pubitemid 28152804)
34. Grotendorst GR, Lau LF, Perbal B. CCN proteins are distinct from and should not be considered members of the insulin-like growth factor-binding protein superfamily. Endocrinology. 2000;141: 2254-2256. (Pubitemid 32274380)
35. Rachfal AW, Brigstock DR. Structural and functional properties of CCN proteins. Vitam Horm. 2005;70:69-103. (Pubitemid 43589023)
36. Lim HW, Lee JE, Shin SJ, et al. Identification of differentially expressed mRNA during pancreas regeneration of rat by mRNA differential display. Biochem Biophys Res Commun. 2002;299:806- 812. (Pubitemid 36034558)
37. Ferrand N, Stragier E, Redeuilh G, Sabbah M. Glucocorticoids induce CCN5/WISP-2 expression and attenuate invasion in oestrogen receptor-negative human breast cancer cells. Biochem J. 2012;447: 71-79.
38. Banerjee S, Saxena N, Sengupta K, Tawfik O, Mayo MS, Banerjee SK. WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation. Neoplasia. 2003;5:63-73. (Pubitemid 36151059)
39. Fritah A, Redeuilh G, Sabbah M. Molecular cloning and characterization of the human WISP-2/CCN5 gene promoter reveal its upregulation by oestrogens. J Endocrinol. 2006;191:613-624. (Pubitemid 46210287)
40. Banerjee S, Sengupta K, Saxena NK, Dhar K, Banerjee SK. Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-γ-positive breast tumor cells through multiple molecular cross-talks. Mol Cancer Res. 2005;3:151-162. (Pubitemid 40524898)
41. Sengupta K, Banerjee S, Dhar K, et al. WISP-2/CCN5 is involved as a novel signaling intermediate in phorbol ester-protein kinase Cα mediated breast tumor cell proliferation. Biochemistry. 2006;45: 10698-10709. (Pubitemid 44320485)
42. Pennica D, Swanson TA, Welsh JW, et al. WISP genes are members of the connective tissue growth factor family that are up-regulated in Wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci. 1998;95:14717-14722. (Pubitemid 29003696)
43. Jin T, George Fantus I, Sun J. Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin. Cell Signal. 2008;20:1697-1704.
44. Ip W, Chiang YT, Jin T. The involvement of the wnt signaling pathway and TCF7L2 in diabetes mellitus: the current understanding, dispute, and perspective. Cell Biosci. 2012;2:28.
45. Lake AC, Bialik A, Walsh K, Castellot JJ Jr. CCN5 is a growth arrest-specific gene that regulates smooth muscle cell proliferation and motility. Am J Pathol. 2003;162:219-231. (Pubitemid 36042004)
46. Chowdhury et al IGF-I Induces CCN5 Expression in Pancreatic Islets Endocrinology, May 2014, 55(5):1629-1642